ASSESSMENT OF THE ABILITY OF SARS-COV-2 STRAINS OF GENETIC VARIANTS B.1.1 AND JN.1 TO EVADE NEUTRALIZING ANTIBODIES FROM 2020 AND 2023 CONVALESCENT PATIENTS

Authors: Pyankov S.A.¹, Zaykovskaya A.V.¹, Rybel A.V.¹, Bodnev S.A.¹, Pyankov O.V.¹
Affiliations:
1. Federal Budgetary Research Institution «State Research Center of Virology and Biotechnology «Vector», Federal Service for Surveillance on Consumer Rights Protection and Human Well-being
Section: ORIGINAL ARTICLES
Submitted: 14.04.2025
Accepted: 29.06.2025
Published: